 |
 | | | | | | |
 | 2014 |
| |
 | 2015 |
| |
 | 2016 |
| |
 | 2017 |
| |
  | 01 |
| |
  | 02 |
| |
  | 03 |
| |
  | 04 |
| |
  | 05 |
| |
  | 06 |
| |
  | 07 |
| |
  | 08 |
| |
| | 08/31/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Presents a New Façade Concept Using Advanced OPV and OLED technology in Seoul | |  |
| | 08/31/2017 | 12:10 AM | | Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in
Hard-to-Treat Cancers | |  |
| | 08/25/2017 | 09:00 AM | | European Commission Grants Approval for Mavenclad (Cladribine Tablets) | |  |
| | 08/23/2017 | 09:00 AM | | Merck KGaA, Darmstadt, Germany Sets Up PMatX Incubator in Israel for Next-Generation Electronics | |  |
| | 08/23/2017 | 11:00 AM | | Merck KGaA, Darmstadt, Germany, to Exhibit at the IAA for the First Time | |  |
| | 08/08/2017 | 02:00 PM | | MilliporeSigma and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases | |  |
| | 08/03/2017 | 10:00 AM | | European Patent Office to Grant Merck KGaA, Darmstadt, Germany’s Patent Application for CRISPR Technology | |  |
| | 08/03/2017 | 06:50 AM | | Executive Board Changes at Merck KGaA, Darmstadt, Germany | |  |
| | 08/03/2017 | 07:00 AM | | Q2 2017: Merck KGaA, Darmstadt, Germany, Sets Course for Future Growth | |  |
  | 09 |
| |
  | 10 |
| |
  | 11 |
| |
  | 12 |
| |
 | 2018 |
| |
|